Company: KEQU
Filing Date: 2025-07-02
Form Type: 10-K
Source: 0000055529-25-000026
Chunk: 25

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-07-02
Form: 10-K
Item: Item 10
Chunk 25
---
 to beissued uponexercise ofoutstandingoptions, warrantsand rightsWeighted-averageexercise price ofoutstanding options,warrants and rightsNumber of securitiesremaining available forfuture issuance underequity compensationplansEquity Compensation Plans approved by Security Holders:2023 Omnibus Incentive Plan187,226 $22.83 357,472 Equity Compensation Plans not approved by Security Holders:— — —  Total Equity Compensation Plans187,226 357,472 

Refer to Note 9, Stock Options and Share-Based Compensation, of the Company's consolidated financial statements included in Item 8 for additional information.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information appearing in the sections entitled "Election of Directors" and "Agreements with Certain Executives" in the Proxy Statement is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services

The information appearing in the section entitled "Ratification of Appointment of Independent Registered Public Accounting Firm—Audit Fees and Non-Audit Fees" in the Proxy Statement is incorporated herein by reference.

56

PART IV

Item 15. Exhibits and Financial Statement Schedules

The following documents are filed or incorporated by reference as part of this Annual Report:

Page(a)(1)Consolidated Financial StatementsReport of Independent Registered Public Accounting Firm22Consolidated Statements of Operations—Years ended April 30, 2025 and 202424Consolidated Statements of Comprehensive Income—Years ended April 30, 2025 and 202425Consolidated Statements of Stockholders' Equity—Years ended April 30, 2025 and 202426Consolidated Balance Sheets—April 30, 2025 and 202427Consolidated Statements of Cash Flows—Years ended April 30, 2025 and 202428Notes to Consolidated Financial Statements30(a)(2)Consolidated Financial Statement SchedulesFinancial statement schedules have been omitted because the information required has been separately disclosed in the consolidated financial statements or related notes.(a)(3)ExhibitsExhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index, which is attached hereto at pages 58 through 60 and which is incorporated herein by reference.

Item 16. Form 10-K Summary

None.

57

KEWAUNEE SCIENTIFIC CORPORATION

Exhibit Index